BL
MRNA icon

Balentine LLC’s Moderna MRNA Stock Holding History

Balentine LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,455
Closed -$298K – 590
2023
Q2 		$298K Buy
2,455
+1,112
+83% +$148K 0.01% 383
2023
Q1 		$206K Sell
1,343
-257
-16% -$42.4K 0.01% 504
2022
Q4 		$287K Buy
+1,600
New +$262K 0.01% 448
2022
Q3 		– Sell
-1,941
Closed -$277K – 671
2022
Q2 		$277K Sell
1,941
-1,401
-42% -$200K 0.01% 451
2022
Q1 		$576K Buy
3,342
+1,240
+59% +$209K 0.02% 270
2021
Q4 		$534K Buy
+2,102
New +$615K 0.02% 159
2020
Q3 		– Sell
-83
Closed -$5K – 599
2020
Q2 		$5K Buy
+83
New +$4.54K ﹤0.01% 731

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Balentine LLC's MRNA Position: Q3 2023 in Review

Balentine LLC sold out of Moderna (MRNA) in Q3 2023, closing a stake of 2,455 shares — an estimated $298K sold.

Balentine LLC first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $576K in Q1 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Balentine LLC reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Balentine LLC sold 2,455 Moderna shares in Q3 2023, an estimated $298K.
  • Balentine LLC first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
  • Balentine LLC's Moderna position peaked at $576K in Q1 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Balentine LLC's 13F filing for Q3 2023, filed 13 Nov 2023.